Endoscopic ablation therapy of Barrett's esophagus

Minerva Gastroenterologica e Dietologica

Volumn 56, Issue 4, 2010, Pages 405-420

  Akiyama, J ^a   Triadafilopoulos, G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Barrett esophagus; Dysplasia; Esophageal neoplasms

Indexed keywords

PROTON PUMP INHIBITOR;

ABLATION THERAPY; BARRETT ESOPHAGUS; CANCER INCIDENCE; CAPSULE ENDOSCOPY; CELL CYCLE REGULATION; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; DOSIMETRY; DRUG MEGADOSE; DYSPLASIA; ENDOSCOPIC ABLATION THERAPY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HIGH GRADE DYSPLASIA; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTESTINE METAPLASIA; PATHOLOGIST; PHOTODYNAMIC THERAPY; QUALITY ADJUSTED LIFE YEAR; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SCREENING; STOMACH FUNDOPLICATION;

BARRETT ESOPHAGUS; BIOPSY; CATHETER ABLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 79952275998     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Fitzgerald RC, Lascar R, Triadafilopoulos G. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression. Aliment Pharmacol Ther 2001;15:269-76. (Pubitemid 32187550)
2. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
3. Sharma P. Barrett's esophagus. N Engl J Med 2009;361:2548-56.
4. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
5. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85. (Pubitemid 29055349)
6. Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am J Gastroenterol 2006;101:1178-82. (Pubitemid 43829978)
7. Kim SL, Waring JP, Spechler SJ, Sampliner RE, Doos WG, Krol WF et al. Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. Gastroenterology 1994;107:945-9. (Pubitemid 24294555)
8. Crooks GW, Lichtenstein GR. Clinical implications of Barrett's esophagus. Arch Intern Med 1996;156:2174-80.
9. Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 2003;98:1931-9. (Pubitemid 37185786)
10. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5. (Pubitemid 27076463)
11. Eckardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 2001;111:33-7. (Pubitemid 32635259)
12. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008;67:394-8. (Pubitemid 351260043)
13. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006;4:566-72. (Pubitemid 44308164)
14. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012-6. (Pubitemid 27476240)
15. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997;92:407-13.
16. Wani S, Puli SR, Shaheen NJ, Westhoff B, Slehria S, Bansal A et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009;104:502-13.
17. Wang KK, Sampliner RE. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus. Am J Gastroenterol 2008;103:788-97.
18. Kadri SR, Lao-Sirieix P, O'Donovan M, Debiram I, Das M, Blazeby JM et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 2010;341:c4372.
19. Bhardwaj A, Hollenbeak CS, Pooran N, Mathew A. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease. Am J Gastroenterol 2009;104:1533-9.
20. Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 2009;104:1356-62.
21. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002;122:633-40. (Pubitemid 34173814)
22. Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005;62:488-98. (Pubitemid 41383764)
23. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK et al. Radiofrequency Ablation in Barrett's Esophagus with Dysplasia. N Engl J Med 2009;360:2277-88.
24. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
25. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-19. (Pubitemid 32523480)
26. Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 2005;40:750-8. (Pubitemid 40978849)
27. Shaheen NJ, Inadomi JM, Overholt BF, Sharma P. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut 2004;53:1736-44. (Pubitemid 39556888)
28. Vij R, Triadafilopoulos G, Owens DK, Kunz P, Sanders GD. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2004;60:739-56.
29. Das A, Wells C, Kim HJ, Fleischer DE, Crowell MD, Sharma VK. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus. Endoscopy 2009;41:400-8.
30. Inadomi JM, Somsouk M, Madanick RD, Thomas JP, Shaheen NJ. A Cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology 2009;136:2101-4.
31. Dunkin BJ, Martinez J, Bejarano PA, Smith CD, Chang K, Livingstone AS et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 2006;20:125-30. (Pubitemid 43097045)
32. Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004;60:1002-10. (Pubitemid 39655483)
33. Smith CD, Bejarano PA, Melvin WS, Patti MG, Muthusamy R, Dunkin BJ. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007;21:560-9.
34. Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients (with video). Gastrointestinal Endoscopy 2007;65:185-95.
35. Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus 2007;20:516-22. (Pubitemid 47617837)
36. Lyday WD, Corbett FS, Kuperman DA, Kalvaria I, Mavrelis PG, Shughoury AB et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010;42:272,8.
37. Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned. Surg Endosc 2009;23:2175-80.
38. Eldaif SM, Lin E, Singh KA, Force SD, Miller DL. Radiofrequency ablation of Barrett's esophagus: short-term results. Ann Thorac Surg 2009;87:405-10; discussion 10-1.
39. Hernandez JC, Reicher S, Chung D, Pham BV, Tsai F, Disibio G et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 2008;40:388-92. (Pubitemid 351696375)
40. Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008;68:867-76.
41. Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008;40:359-69. (Pubitemid 351696372)
42. Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008;40:370-9. (Pubitemid 351696373)
43. Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 2008;40:380-7. (Pubitemid 351696374)
44. Ganz R, Overholt B, Sharma V, Fleischer D, Shaheen N, Lightdale C et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc [Multicenter Study] 2008;68:35-40.
45. Sharma VK, Jae Kim H, Das A, Wells CD, Nguyen CC, Fleischer DE. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009;104:310-7.
46. Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, Ten Kate FJ, Fockens P et al. Efficacy of Radiofrequency Ablation Combined With Endoscopic Resection for Barrett's Esophagus With Early Neoplasia. Clinical Gastroenterology and Hepatology 2010;8:23-9.
47. Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multi-center trial. Endoscopy 2010;42:781-9.
48. Crockett SD, Lippmann QK, Dellon ES, Shaheen NJ. Health-related quality of life in patients with Barrett's esophagus: a systematic review. Clin Gastroenterol Hepatol 2009;7:613-23.
49. Shaheen NJ, Peery AF, Hawes RH, Rothstein RI, Spechler SJ, Galanko JA et al. Quality of life following radiofrequency ablation of dysplasitic Barrett's esophagus. Endoscopy 2010;42:790-9.
50. Finkelstein SD, Lyday WD. M1944 The molecular pathology of radiofrequency mucosal ablation of Barrett's esophagus. Gastroenterology 2008;134(4, Suppl. 1):A-436.
51. Pouw RE, Gondrie JJ, Rygiel AM, Sondermeijer CM, ten Kate FJ, Odze RD et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol 2009;1041366-73.
52. Fleischer DE, Odze R, Overholt BF, Carroll J, Chang KJ, Das A et al. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus. Dig Dis Sci 2010;55:1918-31.
53. Landreneau RJ, Wiechmann RJ, Hazelrigg SR, Santucci TS, Boley TM, Magee MJ et al. Success of laparoscopic fundoplication for gastroesophageal reflux disease. Ann Thorac Surg 1998;66:1886-92.
54. Ozmen V, Oran ES, Gorgun E, Asoglu O, Igci A, Kecer M et al. Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett's esophagus. Surg Endosc 2006;20:226-9.
55. Watson DI, Foreman D, Devitt PG, Jamieson GG. Preoperative endoscopic grading of esophagitis versus outcome after laparoscopic Nissen fundoplication. Am J Gastroenterol 1997;92:222-5. (Pubitemid 27076465)
56. Triadafilopoulos G. Blitzkrieg for Barrett's esophagus containing early neoplasia. Clin Gastroenterol Hepatol 2010;8:7-9.
57. Peters FP, Kara MA, Rosmolen WD, Aalders MC, Ten Kate FJ, Bultje BC et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005;61:506-14.
58. May A, Gossner L, Pech O, Fritz A, Gunter E, Mayer G et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085-91. (Pubitemid 35178769)
59. Hormi-Carver K, Souza RF. Molecular markers and genetics in cancer development. Surg Oncol Clin N Am 2009;18:453-67.
60. Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN. The molecular biology of esophageal adenocarcinoma. J Surg Oncol 2005 1;92:169-90. (Pubitemid 41779299)
61. Lai LA, Paulson TG, Li X, Sanchez CA, Maley C, Odze RD et al. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer 2007;46:532-42. (Pubitemid 46649568)
62. Li X, Galipeau PC, Sanchez CA, Blount PL, Maley CC, Arnaudo J et al. Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) 2008;1:413-23.
63. Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001;61:8284-9.
64. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000;95:1669-76. (Pubitemid 30485000)
65. Odze RD, Lauwers GY. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy 2008;40:1008-15.
66. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993;104:1686-91. (Pubitemid 23235459)